Stay updated on Dapagliflozin and Metformin in GDM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.
Latest updates to the Dapagliflozin and Metformin in GDM Clinical Trial page
- Check3 days agoChange DetectedRevision updated to v3.3.4; the previous revision v3.3.3 is replaced.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study locations section now includes Louisiana as a location to indicate where the trial is conducted.SummaryDifference0.2%
- Check52 days agoChange DetectedPublications section wording updated to indicate PubMed-based publication notes and the revision label updated to v3.3.2, replacing the previous note and v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check59 days agoChange DetectedNotice about government funding status was removed from the page, which does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check74 days agoChange DetectedThe Study Details content appears unchanged, with the same design, interventions, and eligibility criteria as before. No substantive updates to primary outcomes or study status are evident in the provided screenshots.SummaryDifference0.4%
- Check103 days agoChange DetectedCore content updated to include funding and operating status notice and a new version number v3.2.0; previous version v3.1.0 was removed.SummaryDifference3%
Stay in the know with updates to Dapagliflozin and Metformin in GDM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.